Discussant panel

6 More presentations in this session

Safety and tolerability of a 5 mg starting dose of vericiguat among patients with heart failure: the VELOCITY study

Professor S. Greene (Durham, US)

Slides Video

Cardiopulmonary exercise testing as a novel endpoint in clinical trials on ATTR amyloid cardiomyopathy

Doctor A. Porcari (London, GB)

Slides Video

Efficacy and safety of aficamten in patients with obstructive hypertrophic cardiomyopathy and mild symptoms

Professor I. Olivotto (Florence, IT)

Slides Video

Pulmonary artery denervation clinical study using the gradient denervation system in heart failure patients with pulmonary hypertension group 2

Doctor J. Nunez Villota (Valencia, ES)

Slides Video

Hemodynamic effects of TX45 , a long-acting Fc-relaxin fusion, in Group 2 pulmonary hypertension patients.

Doctor A. Muslin (Watertown, US)

Slides Video